# The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension

> **NCT00438945** · PHASE4 · COMPLETED · sponsor: **Regional Hospital Holstebro** · enrollment: 18 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Eprosartan

## Key facts

- **NCT ID:** NCT00438945
- **Lead sponsor:** Regional Hospital Holstebro
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2008-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2008-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00438945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00438945, "The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00438945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*